Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 58,492 | 58,810 | 59,203 | 55,312 | 54,264 |
| Gross Profit | 58,492 | 58,810 | 59,203 | 55,312 | 54,264 |
| Operating Expenses | 34,842 | 31,208 | 32,024 | 30,968 | 29,835 |
| Operating Income | 23,650 | 27,602 | 27,179 | 24,344 | 24,429 |
| Interest Expense | 8,778 | 8,649 | 9,265 | 8,883 | 8,795 |
| Other Income | 41 | -779 | 1 | 1 | 4 |
| Pre-tax Income | 14,913 | 18,174 | 17,915 | 15,462 | 15,638 |
| Income Tax | 1,342 | 2,334 | 1,482 | 1,968 | 1,407 |
| Net Income Continuous | 13,571 | 15,840 | 16,433 | 13,494 | 14,231 |
| Minority Interests | 29 | 65 | 38 | 48 | -40 |
| Net Income | $13,542 | $15,775 | $16,395 | $13,446 | $14,271 |
| EPS Basic Total Ops | 0.65 | 0.86 | 0.78 | 0.61 | 0.64 |
| EPS Basic Continuous Ops | 0.65 | 0.85 | 0.78 | 0.62 | 0.64 |
| EPS Diluted Total Ops | 0.64 | 0.83 | 0.77 | 0.60 | 0.63 |
| EPS Diluted Continuous Ops | 0.64 | 0.83 | 0.77 | 0.60 | 0.63 |
| EBITDA(a) | $45,756 | $49,487 | $48,134 | $44,314 | $44,005 |